Latest KFF Health News Stories
Save Billions or Stick With Humira? Drug Brokers Steer Americans to the Costly Choice
Thousands of patients with autoimmune diseases who rely on Humira, with a list price of $6,600 a month, could get financial relief from new low-cost rivals. So far, the pharmacy benefit managers that control drug prices in America have not delivered on those savings.
Humira lleva 20 años disfrutando de una exclusividad muy cara en el país. Sus competidores podrían ahorrarle al sistema sanitario $9,000 millones.
Meet the People Deciding How to Spend $50 Billion in Opioid Settlement Cash
As settlement dollars land at the state level, state councils wield significant power in determining how the windfall gets spent. And, though they will likely include the most knowledgeable voices on addiction, these panels also face concerns about conflicts of interest and other issues.
Once-Resistant Rural Court Officials Begin to Embrace Medications to Treat Addiction
As evidence supporting medication treatment for opioid addiction mounts, judges, district attorneys, and law enforcement officials in rural America are increasingly open to it after years of insisting on abstinence only.
The Hospital Bills Didn’t Find Her, but a Lawsuit Did — Plus Interest
Recovering from emergency gallbladder surgery, a Tennessee woman said she spent months without a permanent mailing address and never got a bill. She was sued by the health system two years later.
Doctor Lands in the Doghouse After Giving Covid Vaccine Waivers Too Freely
Richard Coble issued vaccine waivers to patients in at least three states without examining them. He was exposed by a Nashville TV station that bought a waiver for a Labrador retriever named Charlie.
A Catch-22 for Clinics: State Bans Limit Abortion Counseling. Federal Title X Rules Require It.
Family planning clinics are getting caught between state abortion bans and a federal requirement to refer patients for abortion care on request.
A Covid Test Medicare Scam May Be a Trial Run for Further Fraud
Before the covid-19 public health emergency ended, Medicare advocates around the country noticed a rise in complaints from beneficiaries who received at-home covid tests they never requested. Bad actors may have used seniors’ Medicare information to improperly bill the federal government — and could do it again, say federal investigators.
Estafas a Medicare con pruebas para covid pueden generar otros fraudes
La cobertura de Medicare para las pruebas caseras de covid-19 finalizó hace pocos días, pero las estafas generadas por este beneficio temporal podrían tener consecuencias persistentes para las personas mayores.
A Rural County’s Choice: Use Opioid Funds to Pay Off Debt, or Pay Them Forward to Curb Crisis
Greene County, Tennessee, so far has received more than $2.7 million from regional and national settlements with opioid manufacturers and distributors. But most of the money is not going to help people and families harmed by addiction.
PBMs, the Brokers Who Control Drug Prices, Finally Get Washington’s Attention
Drugmakers, pharmacies, and physicians blame pharmacy benefit managers for high drug prices. Congress is finally on board, too, but will it matter?
The Biden Administration Vowed to Be a Leading Voice on Opioid Settlements But Has Gone Quiet
Billions of dollars are headed to state and local governments to address the opioid crisis. Policy experts and advocates expect the federal government to play a role in overseeing the use of the money. Failure to do so, they say, could lead to wasted opportunities. And, since Medicaid helps pay health care costs, the feds could have a claim to portions of states’ opioid settlements.
Feds Launch Criminal Investigation Into ‘AGGA’ Dental Device and Its Inventor
KFF Health News and CBS News recently reported that multiple lawsuits allege the device has led to grievous injuries to patients’ mouths, resulting in loss of teeth.
FDA Evaluates ‘Safety Concerns’ Over Dental Devices Featured in KHN-CBS Investigation
A KHN and CBS News investigation found that a dental appliance called the AGGA has been used by more than 10,000 patients, and multiple lawsuits allege it has caused grievous harm to patients.
ER’s Error Lands a 4-Year-Old in Collections (For Care He Didn’t Receive)
A Florida woman tried to dispute an emergency room bill, but the hospital and collection agency refused to talk to her — because it was her child’s name on the bill, not hers.
Truly Random Drug Testing: ADHD Patients Face Uneven Urine Screens and, Sometimes, Stigma
Doctors have no national standards on when to order urine tests to check whether adult ADHD patients are properly taking their prescription stimulants. Some patients are subjected to much more frequent testing than others.
A los pocos meses de usar AGGA, una paciente dijo que sus dientes estaban tan flojos que podía sentir cómo se movían cuando se untaba crema hidratante en las mejillas. Besar a su novio le resultaba incómodo.
Watch: Dental Device at Center of Lawsuits Was Used on Patients Without FDA Review
More than 10,000 dental patients have been fitted with an Anterior Growth Guidance Appliance, or AGGA, according to court records. But the unproven and unregulated device has not been evaluated by the FDA, according to a months-long joint investigation by KHN and CBS News.
This Dental Device Was Sold to Fix Patients’ Jaws. Lawsuits Claim It Wrecked Their Teeth.
A dental device called AGGA has been used on about 10,000 patients without FDA approval or proof that it works. In lawsuits, patients report irreparable harm. The AGGA’s inventor and manufacturer have denied all liability in court.
NYC Makes Clear Its Intent to Lead on Abortion Access
Mayor Eric Adams’ announcement this year to provide abortion pills free of charge at four of New York’s sexual health clinics is the city’s latest move on abortion access. Other jurisdictions are also taking steps.
